Anticoagulant therapy: basic principles, classic approaches and recent developments.

Area of Science:

• Pharmacology
• Hematology
• Medical Chemistry

Background:

• Standard anticoagulants, including unfractionated heparins, low molecular weight heparins, and vitamin K antagonists, are mainstays in managing and preventing thrombotic events.
• These agents are crucial for conditions such as deep vein thrombosis, pulmonary embolism, stroke, and myocardial infarction.

Purpose of the Study:

• To review the advantages and limitations of current standard anticoagulants.
• To survey contemporary trends in utilizing small, selective direct inhibitors of thrombin and factor Xa.
• To discuss the ongoing search for novel targets within the coagulation cascade for next-generation anticoagulants.

Main Methods:

• Literature review and analysis of existing anticoagulant therapies.
• Survey of recent advancements in direct thrombin and factor Xa inhibitors.
• Discussion of emerging research in coagulation cascade targets.

Main Results:

• Standard anticoagulants possess both benefits and drawbacks in clinical application.
• Selective direct inhibitors represent a modern approach with distinct pharmacological profiles.
• Identification of new targets in coagulation is key to developing improved antithrombotic strategies.

Conclusions:

• Current anticoagulants have limitations that necessitate the development of safer and more effective alternatives.
• Direct acting oral anticoagulants (DOACs) and other selective inhibitors offer advancements in antithrombotic therapy.
• Continued research into the coagulation cascade holds promise for future innovations in preventing and treating thrombosis.